Journal of Pharmaceutical Policy and Practice

Featured article

Evaluating the impact of Brexit on the pharmaceutical industry

Kazzazi et al.

Articles

Recent
Most accessed

Content type: Research
| 19 July 2018

A qualitative exploration of knowledge, attitudes and practices of hospital pharmacists towards adverse drug reaction reporting system in Lahore, Pakistan

Authors: Rabia Hussain, Mohamed Azmi Hassali, Furqan Hashmi and Maryam Farooqui
Content type: Letter to the editor
| 16 July 2018

Comment on Hernandez-Vasquez et al., a bibliometric analysis of the global research on biosimilars

Authors: Hillel P. Cohen
Content type: Research
| 5 July 2018

Article 2: Longitudinal study assessing the one-year effects of supervision performance assessment and recognition strategy (SPARS) to improve medicines management in Uganda health facilities

Authors: Birna Trap, Richard Musoke, Anthony Kirunda, Martin Olowo Oteba, Martha Embrey and Dennis Ross-Degnan
Content type: Research
| 21 June 2018

Regulatory requirements for the registration of generic medicines and format of drug dossiers: procedures in Sri Lanka in comparison with selected regulatory authorities

Authors: D. Thambavita, P. Galappatthy and R. L. Jayakody
Content type: Research
| 7 June 2018

Assessment of primary labeling of medicines manufactured by Nepalese pharmaceutical industries

Authors: Ramesh Sharma Poudel, Shakti Shrestha, Santosh Thapa, Bhupendra Kumar Poudel and Muniraj Chhetri

Most recent articles RSS

View all articles

Content type: Research
| 13 June 2013

Antimicrobial sensitivity patterns of cerebrospinal fluid (CSF) isolates in Namibia: implications for empirical antibiotic treatment of meningitis

Authors: Assegid Mengistu, Johannes Gaeseb, Gottfried Uaaka, Christophine Ndjavera, Kennedy Kambyambya, Lazarus Indongo, Francis Kalemeera, Christopher Ntege, David Mabirizi, Mohan P Joshi and Evans Sagwa
Content type: Research
| 12 August 2013

Access to antibiotics in New Delhi, India: implications for antibiotic policy

Authors: Anita Kotwani and Kathleen Holloway
Content type: Review
| 10 July 2013

National medicines policies – a review of the evolution and development processes

Authors: Joëlle M Hoebert, Liset van Dijk, Aukje K Mantel-Teeuwisse, Hubert GM Leufkens and Richard O Laing
Content type: Research
| 13 June 2013

Evaluating patients’ perceptions regarding generic medicines in Jordan

Authors: Faris El-Dahiyat and Reem Kayyali
Content type: Research
| 13 June 2013

Assessment of the therapeutic value of new medicines marketed in Australia

Authors: Agnes I Vitry, Ng Huah Shin and Pauline Vitre

Most accessed articles RSS

View all articles

Uniquely positioned as an interactive platform for pioneering pharmaceutical policy research in developed and developing countries, Journal of Pharmaceutical Policy and Practice disseminates empirical research in all aspects of pharmacy including clinical, social, administrative or economic. Dedicated to furthering our vision that people everywhere should have access to the medicines they need and use them rationally, we share new evidence, key issues and perspectives in pharmaceutical policy and practice from researchers, academics and practitioners at local and global levels.

New thematic series

Cross journal collection
Medicine and the Future of Health
Guest editors: Dr Zaheer-Ud-Din Babar, Dr Dale Fisher and Dr Paul Wicks

Call for papers

JoPPP series on access to medicines, pricing, generics, biologics

Series Editors: Andy Gray, Fatima Suleman, Zaheer-Ud-Din Babar

Submission deadline: 31^st July 2018

Series publication date: October 2018

Latest Tweets

'On Health' blog

Risk and hardship on the way to Europe: what makes women migrants vulnerable in EU borderlands?

06 July 2018
Quo vadis blockchain in health and healthcare?

05 July 2018
Controlling epidemics using mobile phone data

27 June 2018

About the Editor

Zaheer-Ud-Din Babar is Professor in Medicines and Healthcare at the Department of Pharmacy, University of Huddersfield, United Kingdom.

He is globally recognized for his research in pharmaceutical policy and practice, including the quality use of medicines, clinical pharmacy practice, access to medicines and issues related to pharmacoeconomics. Previously he was the Head of Pharmacy Practice at School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, New Zealand. A pharmacist by training and a Ph.D. in pharmacy practice, Dr. Babar is the recipient of prestigious “Research Excellence Award” from the University of Auckland.

Journal history

In December 2008, Southern Med Review was started by Dr Zaheer Babar to promote pharmaceutical policy research at a global level. It was a biannual publication, and it published more than 70 papers till December 2012, with authors from 45 countries. The journal has been unique in publishing the work of new researchers, documenting the pharmaceutical situation of low- and middle-income countries and debating pertinent pharmaceutical policy questions. The journal's work has been recognized at a global level and, according to WHO, it fulfilled a global need. For example, published studies have been instrumental in changing medicines policies in certain regions, especially in Vietnam and Thailand. The journal is indexed in Scopus, EMBASE and PubMed Central and in 2013 has been relaunched as Journal of Pharmaceutical Policy and Practice by BioMed Central.

Journal of Pharmaceutical Policy and Practice is affiliated with The University of Auckland and Auckland UniServices Ltd.

Archival content

An electronic archive of content under the journal's previous name Southern Med Review (2009-2012) can be found on PubMed Central.

Journal of Pharmaceutical Policy and Practice

Featured article

Articles

A qualitative exploration of knowledge, attitudes and practices of hospital pharmacists towards adverse drug reaction reporting system in Lahore, Pakistan

Comment on Hernandez-Vasquez et al., a bibliometric analysis of the global research on biosimilars

Article 2: Longitudinal study assessing the one-year effects of supervision performance assessment and recognition strategy (SPARS) to improve medicines management in Uganda health facilities

Regulatory requirements for the registration of generic medicines and format of drug dossiers: procedures in Sri Lanka in comparison with selected regulatory authorities

Assessment of primary labeling of medicines manufactured by Nepalese pharmaceutical industries

Antimicrobial sensitivity patterns of cerebrospinal fluid (CSF) isolates in Namibia: implications for empirical antibiotic treatment of meningitis

Access to antibiotics in New Delhi, India: implications for antibiotic policy

National medicines policies – a review of the evolution and development processes

Evaluating patients’ perceptions regarding generic medicines in Jordan

Assessment of the therapeutic value of new medicines marketed in Australia

Aims and scope

New thematic series

Call for papers

Latest Tweets

'On Health' blog

Risk and hardship on the way to Europe: what makes women migrants vulnerable in EU borderlands?

Quo vadis blockchain in health and healthcare?

Controlling epidemics using mobile phone data

About the Editor

Journal history

Archival content

Follow

2017 Journal Metrics

Journal of Pharmaceutical Policy and Practice

Contact us